Active 340B contract pharmacies reached 17,250 in 2024, according to a conservative think tank using data collected by another group funded by [...] …
Category: Pharma Industry
Bristol Myers Squibb (BMS), Amgen, and Bayer became the latest drugmakers to formally exempt Arkansas providers from their 340B contract [...] …
Drugmaker Sumitomo Pharma America (SMPA) announced it will implement first-time contract pharmacy restrictions next month. The biotech company, which is [...] …
Japanese drugmaker Astellas will soon extend its limits on 340B pricing to hospitals for its medication to treat overreactive bladder, [...] …
Drugmakers Amgen and Johnson & Johnson have announced they will provide refunds to 340B providers on past purchases of multiple [...] …
Eighty-five percent of DSH hospitals earned more in estimated 340B revenue in 2022 than they incurred in charity care costs, [...] …
After a federal appeals court upheld Arkansas’ 340B contract pharmacy access law, a major drug manufacturer has asked a federal [...] …
A federal judge recently dismissed a large California health system’s whistleblower case against four pharmaceutical companies for alleged fraudulent 340B [...] …
Two More Drugmakers End 340B Contract Pharmacy Restrictions in Arkansas After Appeals Court Decision
Drugmakers EMD Serono and Sanofi will lift 340B contract pharmacy restrictions in Arkansas after a federal appeals court upheld a [...] …
Months after nine drug manufacturers restored 340B contract pharmacy access in Arkansas, two more companies have announced they will exempt [...] …